• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2026, Vol. 28 ›› Issue (1): 28-28-30.doi: 10.1009-0959.2026.020001

• 监管科学 • 上一篇    下一篇

监管改革推动医疗器械产业创新发展的思考

汪淑梅   

  1. 上海联影医疗科技股份有限公司,上海 201807
  • 收稿日期:2025-03-13 接受日期:2025-11-15 出版日期:2026-01-28 发布日期:2026-02-11

Innovation and Development in the Medical Device Industry Under Regulatory Reform

WANG Shumei   

  1. Shanghai United Imaging Healthcare Co. Ltd. Shanghai 201807, China
  • Received:2025-03-13 Accepted:2025-11-15 Online:2026-01-28 Published:2026-02-11

摘要:

随着全球医药技术的快速发展,我国生物医药产业也进入转型升级和高质量发展的关键时期。国务院办公厅发布的《关于全面深化药品医疗器械监管改革促进医药产业高质量发展的意见》(以下简称《意见》),以新质生产力为引领,通过全面深化药品医疗器械监管改革,优化审评审批流程,强化监管效能,为实现行业高质量发展注入强劲动力,满足人民群众对健康福祉的更高追求。本研究从医疗器械行业的角度,分析《意见》的具体内容及其影响,探讨这些改革措施如何促进医疗器械行业的创新和发展,提高产品的安全性和有效性,以及增强企业的合规意识和社会责任感,进而深入理解该《意见》对于企业创新发展的双轮驱动作用。


关键词:  , 医疗器械;监管改革;审评审批;合规水平;高质量发展

Abstract:

With the rapid development of global medicine technology China's biornedicine industry has entered a crucial stage of transformation upgrading and high-quality development. The "Opinions on Comprehensively Deepening Drug and Medical Device Regulatory Reforms to Promote High-Quality Development of the Pharmaceutical Industry" issued by the General Office of the State Council provides strong momentum for achieving high-quality industry development. Guided by the concept of new quality productive forces these reforms comprehensively deepen regulatory improvements for drugs and medical devices optimize review and approval processes and enhance regulatory efficiency which aim to meet people's higer aspirations for health and well-being. This article provides an in-depth analysis of the specific contents and implications of the "Opinions on Comprehensively Deepening Drug and Medical Device Regulatory Reforms to Promote High-Quality Development of the Pharmaceutical Industry" from the perspective of the medical device industry explores how these reform measures can foster innovation and development in the medical device industry improve the safety and efficacy of products and strengthen corporate compliance awareness and social responsibility.


Key words: Medical Device , Regulatory reform , Review and approve , Compliance level , High-quality development

中图分类号: